ADVERTORIAL
Separating Fact From Fiction: Debunking the Top 5 Myths About Ozempic® and Weight Loss Medications.
From Hollywood to Main Street, drugs like Ozempic® and Wegovy® (also known as Semaglutide, or GLP1s) have taken the world by storm. Ordinary people have achieved body transformations that were once thought impossible — but with media craze comes confusion. Today we will Fact Check some of the most prevalent myths about these weight loss drugs.
By: Jordan Michael
Published: June 2, 2024
Myth #1: Semaglutide is a New and Untested Drug
Rating:
Rating:
Context:
Semaglutide (the active ingredient in Ozempic® and Wegovy®) was first examined in clinical trials in the early 2010's as a treatment for Diabetes. The earliest studies focused on measuring the drug's safety, and pharmacodynamics. In 2012, Phase 2 clinical trials examined the efficacy and optimal dosages needed to manage blood sugar levels. Then, Phase 3 clinical trials in 2013 involved thousands of people, and found evidence for a variety of benefits beyond blood sugar management, including weight loss. This led to an FDA approval for Semaglutide (under the brand name Wegovy®) for weight loss on June 4, 2021.
Semaglutide (the active ingredient in Ozempic® and Wegovy®) was first examined in clinical trials in the early 2010's as a treatment for Diabetes. Early Studies focused on measuring the drug's safety. In 2012, Phase 2 clinical trials examined the efficacy and optimal dosages for managing blood sugar levels. Then, Phase 3 clinical tirals in 2013 involved thousands of people, and found a variety of benefits beyond blood sugar management, including weight loss. This led to an FDA approval for Semaglutide (under the brand name Wegovy®) for weight loss on June 4, 2021.
Myth #2: Semaglutide is Only for Severely Obese People
Rating:
Rating:
Context:
Any person who is considered medically overweight (having a BMI of 27 or greater) and has at least one weight-related health condition such as hypertension, type 2 diabetes, or dyslipidemia can be considered eligible to qualify for an Ozempic®, Wegovy®, or non-branded Compounded Semaglutide prescription for weight loss. A doctor will screen the patient for circumstances that exclude a patient such as an allergy to Semaglutide or family histories of specific diseases.
Myth #3: Semaglutide has Dangerous, Severe Side Effects
Rating:
Rating:
Context:
While all medications have potential side effects, the weight loss medications available on the market have been thoroughly tested and are deemed safe when used under medical supervision. The most common side effects are gastrointestinal in nature and include nausea, constipation, and indigestion. Most side effects fade over time, and are easily treatable in the short term with other safe, commonly used medications. Like all medications, a healthcare professional should monitor how your body responds to it, and adjust dosage as necessary.
While all medications have potential side effects, the weight loss medications available on the market have been thoroughly tested and are deemed safe when used under medical supervision. The most common side effects include nausea, constipation, and indigestion. Most side effects fade over time, and are easily treatable in the short term. Like all medications, a healthcare professional should monitor how your body responds to it, and adjust dosage as necessary.
Myth #4: Ozempic® is Prohibitively Expensive
Rating:
Rating:
Context:
While it's true that name brand drugs like Ozempic® can cost over $1,000 per month, those are NOT the only available options for clinically proven weight loss drugs. Compounded Semaglutide is a newly available pharmaceutical that uses the SAME active ingredient as Ozempic® and Wegovy®, but does not have the pricy brand name attached to it. The drug has the same clinical efficacy for weight loss, and the same limited side effect profile, except costs only a third of the price. This is how ordinary people have been able to get their hands on what was once seen as a "celebrity weight loss hack."
Myth #5: Weight Loss Medication Requires a Prescription
Rating:
Rating:
Context:
Every legitimate, clinically proven weight loss drug requires a prescription in the United States. In years past, this was a major road block for ordinary people to get these drugs. Fortunately, new companies like Remote Pharmacy allow ANYONE to go online and speak to a doctor to get a prescription, and even have the medication shipped to their door. Even though this sounds too-good-to-be-true, you can visit this link to verify it's status as a trusted and legal telehealth provider. They offer a full range of options including name-brand Ozempic® and Wegovy®, as well as Compounded Semaglutide.
INTERESTED IN TRYING SEMAGLUTIDE FOR WEIGHT LOSS?
Remote Pharmacy is offering 50% off your first month of Compounded Semaglutide treatment.
- 100% Online Consultations
- Delivered To Your Door
- No Credit Card Required For First Steps
See if I qualify
LOOKING TO TRY SEMAGLUTIDE FOR WEIGHT LOSS?
Remote Pharmacy is offering 50% off your first month of Compounded Semaglutide
- 100% Online Consultations
- Delivered To Your Door
- No Credit Card Required For First Steps
See if I qualify
1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay,
I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group (2021).
Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England journal of medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
Ozempic® is a registered trademark of Novo Nordisk, Remote Pharmacy is not affiliated with Novo Nordisk. Actual medication appearance may differ. Medication prescriptions are up to a medical provider’s discretion. Visit website for safety information and Terms & Conditions.
A Prescription from a licensed medical professional is required. Results may vary.
GET 50% OFF YOUR FIRST MONTH WITH CODE: 50NEW
Get Started Today
SPECIAL READER DISCOUNT GET 50% OFF YOUR FIRST MONTH WITH CODE: 50NEW
Get Started Today